Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer.

Respiratory research - 9 May 2018

Dou Feifei, Li Huiqiao, Zhu Min, Liang Lirong, Zhang Yuan, Yi Jiawen, Zhang Yuhui

Abstract excerpt

BACKGROUND: Preclinical data suggest that oncogene (EGFR and KRAS) events regulate tumor procoagulant activity. However, few studies have prospectively investigated the clinical relevance between the presence of EGFR or KRAS mutations and occurrence of venous thromboembolism(VTE) in patients with non-small cell lung cancer (NSCLC). METHODS: A total of 605 Chinese patients with newly diagnosed NSCLC were included...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Carcinoma, Non-Small-Cell Lung

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cohort Studies

Share to Genes, erbB-1

Share to Genetic Association Studies

Share to Lung Neoplasms

Share to Proto-Oncogene Proteins p21(ras)

Share to Venous Thromboembolism

Source

Open in PubMed Open full text

Identifiers

PMID: 29743116
DOI: 10.1186/s12931-018-0791-2
PMCID: PMC5944093

Genes

EGFR
KRAS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association between oncogenic status and risk of venous thromboembolism in patients with non-small cell lung cancer.PMID 29743116Read ↗

Mutations in NSCLC and their link with lung cancer-associated thrombosis: a case-control study.Semantic proximity Read ↗

Common genetic driver mutation in NSCLC and their association with thromboembolic events: A retrospective study.Semantic proximity Read ↗

Risk factors and prognostic impact of venous thromboembolism in Asian patients with non-small cell lung cancer.Semantic proximity Read ↗

Association of ALK rearrangement and risk of venous thromboembolism in patients with non-small cell lung cancer: A prospective cohort study.Semantic proximity Read ↗

Risk of thromboembolism in patients with ALK- and EGFR-mutant lung cancer: A cohort study.Semantic proximity Read ↗

Association between genetic mutations and risk of venous thromboembolism in patients with solid tumor malignancies: A systematic review and meta-analysis.Semantic proximity Read ↗

Risk of thromboembolism in non-small-cell lung cancers patients with different oncogenic drivers, including ROS1, ALK, and EGFR mutations.Semantic proximity Read ↗

Cancer genetic profile and risk of thrombosis.Semantic proximity Read ↗

Tumor oncogene (KRAS) status and risk of venous thrombosis in patients with metastatic colorectal cancer.Semantic proximity Read ↗

Brief report: High incidence of peridiagnosis thromboembolic events in patients with BRAF-mutant lung cancer.Semantic proximity Read ↗

Identification of critical genes and pathways related to venous thromboembolism in non-small cell lung cancer patients using integrated bioinformatics analysisSemantic proximity Read ↗

Incidence of venous thromboembolism in patients with colorectal cancer according to oncogenic status.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.